Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

NCT01667419

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Department of Medicine; Division of Hematology / Oncology California City, California, United States
  • Kaiser Permanente - Hayward Hayward, California, United States
  • UCLA Hematology Oncology - Irvine Irvine, California, United States
View all 207 locations
View Trial Details
Completed

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436852

Conditions
Disseminated Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
View Trial Details
Completed

Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00486603

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

NCT01227551

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Moores UCSD Cancer Center La Jolla, California, United States
  • St Mary's Medical Center San Francisco, California, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details

Related conditions